These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 10468245

  • 1. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 2. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 3. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [Abstract] [Full Text] [Related]

  • 4. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
    Malviya S.
    Semin Thromb Hemost; 1997 Nov 04; 23(6):563-7. PubMed ID: 9469631
    [Abstract] [Full Text] [Related]

  • 5. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
    Koster A, Fischer T, Gruendel M, Mappes A, Kuebler WM, Bauer M, Kuppe H.
    J Cardiothorac Vasc Anesth; 2003 Apr 04; 17(2):171-5. PubMed ID: 12698397
    [Abstract] [Full Text] [Related]

  • 6. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M.
    Thromb Haemost; 1997 Feb 04; 77(2):270-7. PubMed ID: 9157580
    [Abstract] [Full Text] [Related]

  • 7. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT.
    Thromb Haemost; 1996 Dec 04; 76(6):902-8. PubMed ID: 8972009
    [Abstract] [Full Text] [Related]

  • 8. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 9. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Bajaj T, Fazlollah T, Szlam F, Wilson E, Kaiser A, Tosone SR, Miller BE.
    Anesth Analg; 2008 Feb 02; 106(2):419-25, table of contents. PubMed ID: 18227295
    [Abstract] [Full Text] [Related]

  • 10. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery.
    Chomiak PN, Walenga JM, Koza MJ, Reilly TM, Turlapathy P, Pifarre R.
    Circulation; 1993 Nov 02; 88(5 Pt 2):II407-12. PubMed ID: 7993389
    [Abstract] [Full Text] [Related]

  • 11. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T, Gando S, Kemmotsu O, Mashio H, Goda Y, Kawahigashi H, Watanabe N.
    J Cardiothorac Vasc Anesth; 2001 Feb 02; 15(1):60-4. PubMed ID: 11254842
    [Abstract] [Full Text] [Related]

  • 12. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ.
    Semin Thromb Hemost; 2005 Feb 02; 31(4):426-40. PubMed ID: 16149021
    [Abstract] [Full Text] [Related]

  • 13. [Anticoagulant therapy and cardiopulmonary bypass].
    Lespron Robles Mdel C, Molina Méndez J.
    Arch Cardiol Mex; 2007 Feb 02; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
    [Abstract] [Full Text] [Related]

  • 14. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb 02; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 15. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W.
    J Cardiovasc Pharmacol; 1996 Feb 02; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [Abstract] [Full Text] [Related]

  • 16. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar 02; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 17. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M.
    Can J Anaesth; 1999 Jun 02; 46(6):581-5. PubMed ID: 10391608
    [Abstract] [Full Text] [Related]

  • 18. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP, Heller W, Gallimore MJ, Bantel H, Müller-Beissenhirtz H, Hoffmeister HE.
    Blood Coagul Fibrinolysis; 1993 Feb 02; 4(1):41-5. PubMed ID: 7681331
    [Abstract] [Full Text] [Related]

  • 19. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ, Velan T, Aldea GS, Chandler WL.
    Thromb Res; 2006 Feb 02; 117(6):689-703. PubMed ID: 15996721
    [Abstract] [Full Text] [Related]

  • 20. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul 02; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.